Health and Ageing

Pharmaceutical Benefits Advisory Committee — cost recovery arrangements

Revenue ($m)

	2005-06	2006-07	2007-08	2008-09
Department of Health and Ageing	-	-	11.1	11.2
Related expense ($m)
Department of Health and Ageing	0.6	1.5	0.6	0.6
Related capital ($m)
Department of health and Ageing	-	0.4	-	-

From 1 July 2007, the Government will recover the costs of the Pharmaceutical Benefits Advisory Committee’s review of submissions for new listings on the Pharmaceutical Benefits Scheme, leading to additional revenue of $22.3 million over four years.

Cost recovery will occur by charging fees to companies making submissions to the Pharmaceutical Benefits Advisory Committee.

The Department of Health and Ageing will be provided with $3.7 million over four years (including $0.4 million of capital funding) to establish and manage the cost recovery process.

---